Back Pain News and Research

Latest Back Pain News and Research

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

A post-hoc analysis of a Phase 3 safety study demonstrated that NUCYNTA® (tapentadol) tablets were associated with a lower incidence of nausea, vomiting and constipation when compared to oxycodone immediate release (IR) tablets in elderly patients with moderate to severe low-back or osteoarthritis pain.

7 May 2010

DXA testing can prevent osteoporosis in at-risk women

Geisinger has exceeded the national benchmark for testing women who are at risk for developing osteoporosis - a silent and serious disease.

7 May 2010

Southeast Pain Care offers non-addictive alternatives to pain relief

The untimely death of Michael Jackson has brought the issue of pain medication addiction to the forefront of American media recently. The good news for people suffering with pain is that there are several non-addictive alternatives to pain relief.

6 May 2010

FDA approves Provenge for treating men with advanced prostate cancer

The US Food and Drug Administration has approved a new 'cancer vaccine' for treating men with advanced prostate cancer.

6 May 2010

Researchers analyze spine surgery patients' existing comorbdities in relationship to hospital stay, costs

It is estimated that between 75 and 85 percent of all Americans will suffer from low back pain and/or neck pain at some point in their lives. An estimated 12 million Americans suffer from degenerative disc disease, with over one million patients undergoing surgery each year. The cost of treating back pain is currently estimated at more than $100 billion annually in the U.S. Many patients with back pain have comorbidities that impact spine surgery.

5 May 2010

PROVENGE receives FDA approval for treatment of CRPC

Dendreon Corporation today announced that the U.S. Food and Drug Administration has approved PROVENGE (sipuleucel-T), an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic, castrate-resistant (hormone-refractory) prostate cancer.

30 Apr 2010

WellTek reports 115% increase in gross profit for fiscal year 2009

WellTek Incorporated, a global health, fitness and wellness company, is pleased to announce that the Company reported $2.54 million in revenue for the 2009 fiscal year ended December 31, 2009, representing a 15% increase over $2.20 million in revenue posted for 2008. The increase is primarily attributable to international sales by the Company's subsidiary, MedX Limited.

30 Apr 2010

Provenge cellular immunotherapy for men with advanced prostate cancer receives FDA approval

The U.S. Food and Drug Administration today approved Provenge (sipuleucel-T), a new therapy for certain men with advanced prostate cancer that uses their own immune system to fight the disease.

30 Apr 2010

McKesson launches EHR solutions for independent physician practices

According to the American Chiropractic Association, there are more than 60,000 licensed chiropractors in the U.S. serving millions of patients who spend $40 billion annually. Those numbers are climbing as research shows a significant connection between chiropractic services and positive healthcare outcomes.

26 Apr 2010

ACP to provide physicians, patients with evidence-based recommendations for clinical problems

Building on its existing foundation of clinical and public policies, the American College of Physicians announced plans to provide physicians and patients with evidence-based recommendations for specific interventions for a variety of clinical problems.

24 Apr 2010

Prevention and nonsurgical treatment options to prevent low back pain and protect spine

Back and neck problems can be caused by a herniated disc, spinal stenosis, injury, strain or osteoarthritis. "Although more than 75 percent of Americans will experience some back pain during their lifetime, about 90 percent of cases are resolved without surgery," stated John K. Ratliff, MD, FACS, a Philadelphia spine surgeon and American Association of Neurological Surgeons spokesperson.

24 Apr 2010

Facet Solutions announces data from ACADIA lumbar stenosis pilot study

Facet Solutions, Inc. today announced that it has finished compiling two year data from its lumbar stenosis pilot study in the US. At two years, patients in the ACADIA™ study experienced significant and sustained improvement in Oswestry Disability Index, VAS back pain and VAS leg pain. There were no re-operations in any of the patients, and all patients met the definition of success for ODI improvement.

23 Apr 2010

USPTO to issue patent for TruFUSE procedure

minSURG International, Inc. is pleased to announce that the United States Patent and Trademark Office will issue on May 4th, 2010 U.S. Patent No. 7,708,761, entitled "Spinal Plug for a Minimally Invasive Facet Joint Fusion System," which provides the Company patent protection for the TruFUSE procedure.

21 Apr 2010

AdvaMed Dx welcomes Siemens Healthcare Diagnostics as association's newest member

AdvaMed Dx, a division of the Advanced Medical Technology Association focused on topics affecting the in vitro diagnostics industry, is pleased to welcome Siemens Healthcare Diagnostics as the association's newest member. Donal Quinn, chief executive officer of Siemens Healthcare Diagnostics, has been appointed to the AdvaMed Dx Board of Directors.

21 Apr 2010

Alexion Pharmaceuticals completes enrollment in Soliris clinical studies for aHUS

Alexion Pharmaceuticals, Inc. today announced that it has completed enrolling patients in all four previously announced prospective, open-label clinical studies investigating Soliris® (eculizumab) as a potential treatment for patients with atypical Hemolytic Uremic Syndrome (aHUS) being conducted in North America and multiple European countries.

21 Apr 2010

Homeopathy – Is it a safer and effective alternative?

Studies have shown that nearly 45% Britons rely on Homeopathy, a branch of medicine that has been doubted by many and loved by an equal number.

20 Apr 2010

Exercise machine for lumbago

Low back pain (or lumbago) is a common ailment often triggered by something as simple as lifting a suitcase. What is the best way to remedy the situation? An exercise machine designed specifically for back muscles could be the solution according to a new study published in the Journal of the American College of Sports Medicine.

20 Apr 2010

Prostate cancer patients having robotic prostatectomy enjoy significant benefits: Study

A new study of almost 700 patients from The Mount Sinai Medical Center shows that prostate cancer patients who had robotically assisted prostatectomy enjoyed significant benefits over patients who had a traditional open radical prostatectomy, including decreased surgical and recovery time, less blood loss during surgery and significantly shorter hospital stays.

16 Apr 2010

Alexion Pharmaceuticals' Soliris NDA for PNH receives approval in Japan

Alexion Pharmaceuticals, Inc. and Alexion Pharma International Sàrl today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved the Company's New Drug Application (NDA) for the use of Soliris® (eculizumab) as a treatment for patients in Japan with paroxysmal nocturnal hemoglobinuria (PNH).

16 Apr 2010

Trans-urethral prostate hyperthermia treatment offers 100% response rate

According the Dr. Friedrich Douwes, Medical Director of St. George Hospital in Bad Aibling, Germany, president of the German Oncological Society and the author of several hundred scientific articles and books, trans-urethral prostate hyperthermia has a 100% initial response rate.

16 Apr 2010

Back Pain News and Research

Latest Back Pain News and Research

Data comparing NUCYNTA to oxycodone IR for osteoarthritis pain presented at 29th APS

DXA testing can prevent osteoporosis in at-risk women

Southeast Pain Care offers non-addictive alternatives to pain relief

FDA approves Provenge for treating men with advanced prostate cancer

Researchers analyze spine surgery patients' existing comorbdities in relationship to hospital stay, costs

PROVENGE receives FDA approval for treatment of CRPC

WellTek reports 115% increase in gross profit for fiscal year 2009

Provenge cellular immunotherapy for men with advanced prostate cancer receives FDA approval

McKesson launches EHR solutions for independent physician practices

ACP to provide physicians, patients with evidence-based recommendations for clinical problems

Prevention and nonsurgical treatment options to prevent low back pain and protect spine

Facet Solutions announces data from ACADIA lumbar stenosis pilot study

USPTO to issue patent for TruFUSE procedure

AdvaMed Dx welcomes Siemens Healthcare Diagnostics as association's newest member

Alexion Pharmaceuticals completes enrollment in Soliris clinical studies for aHUS

Homeopathy – Is it a safer and effective alternative?

Exercise machine for lumbago

Prostate cancer patients having robotic prostatectomy enjoy significant benefits: Study

Alexion Pharmaceuticals' Soliris NDA for PNH receives approval in Japan

Trans-urethral prostate hyperthermia treatment offers 100% response rate

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Back Pain News and Research

Latest Back Pain News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in